New Test Detects More Cases of Cervical Cancer
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read MorePosted by Andy Lundin | Jun 5, 2024 | Cervical (HPV) |
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read MorePosted by Andy Lundin | Jun 4, 2024 | Gastrointestinal Infections |
The FDA approved Genetic Signatures’ EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated workflow for sale in the U.S.
Read MorePosted by Andy Lundin | May 28, 2024 | Diagnostic Technologies |
Researchers created a flexible sweat-monitoring device that induces sweat through drug stimulation, enabling non-invasive health monitoring.
Read MorePosted by Andy Lundin | May 24, 2024 | Colorectal |
The FDA’s Medical Devices Advisory Committee recommended approval of Guardant Health’s Shield blood test for colorectal cancer screening.
Read MorePosted by Andy Lundin | May 22, 2024 | Cardiovascular |
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read More